We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $705M
1-Year Est. Return 43.01%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
–
AUM
$297M
AUM Growth
+$3.41M
Cap. Flow
-$1.23M
Cap. Flow %
-0.41%
Top 10 Hldgs %
35.07%
Holding
84
New
1
Increased
12
Reduced
45
Closed
2

Top Buys

Rank Stock Value
1
MNDT
Mandiant, Inc. Common Stock
MNDT
+$2.08M
2
IMAX icon
IMAX
IMAX
+$1.69M
3
ADI icon
Analog Devices
ADI
+$584K
4
CLH icon
Clean Harbors
CLH
+$321K
5
STR
QUESTAR CORP
STR
+$301K

Top Sells

Rank Stock Value
1
AXLL
AXIALL CORP COM STK (DE)
AXLL
+$3.79M
2
CNX icon
CNX Resources
CNX
+$559K
3
TMO icon
Thermo Fisher Scientific
TMO
+$435K
4
LEA icon
Lear
LEA
+$242K
5
JPM icon
JPMorgan Chase
JPM
+$193K

Sector Composition

Rank Sector Weight
1 Healthcare 33.97%
2 Financials 11.46%
3 Technology 10.89%
4 Consumer Discretionary 9.35%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$127B
$14M 4.71%
210,311
-2,475
-1% -$163K
SBUX icon
2
Starbucks
SBUX
$118B
$12.4M 4.18%
231,650
-668
-0.3% -$33.9K
TMO icon
3
Thermo Fisher Scientific
TMO
$211B
$11.5M 3.87%
88,728
-3,340
-4% -$435K
JPM icon
4
JPMorgan Chase
JPM
$939B
$11.2M 3.76%
164,897
-2,959
-2% -$193K
LEA icon
5
Lear
LEA
$7.19B
$10.7M 3.61%
95,658
-2,110
-2% -$242K
MON
6
DELISTED
Monsanto Co
MON
$9.72M 3.27%
91,217
-190
-0.2% -$22K
PFE icon
7
Pfizer
PFE
$140B
$9.16M 3.08%
287,996
-791
-0.3% -$25.8K
NVS icon
8
Novartis
NVS
$295B
$8.88M 2.99%
100,816
-1,596
-2% -$146K
JNJ icon
9
Johnson & Johnson
JNJ
$635B
$8.3M 2.8%
85,219
-1,625
-2% -$163K
MS icon
10
Morgan Stanley
MS
$337B
$8.29M 2.79%
213,768
-1,620
-0.8% -$61.6K
EOG icon
11
EOG Resources
EOG
$78B
$8.13M 2.74%
92,860
-1,810
-2% -$167K
GE icon
12
GE Aerospace
GE
$367B
$7.54M 2.54%
59,234
+1,563
+3% +$203K
STI
13
DELISTED
SunTrust Banks, Inc.
STI
$7.15M 2.41%
166,251
-1,120
-0.7% -$47.6K
AAPL icon
14
Apple
AAPL
$4.89T
$6.97M 2.34%
222,172
-700
-0.3% -$22.4K
CELG
15
DELISTED
Celgene Corp
CELG
$6.85M 2.3%
59,154
-160
-0.3% -$18.3K
DIS icon
16
Walt Disney
DIS
$165B
$6.76M 2.28%
59,222
-300
-0.5% -$32.9K
CSCO icon
17
Cisco
CSCO
$450B
$6.66M 2.24%
242,660
-640
-0.3% -$18.4K
SLB icon
18
SLB Ltd
SLB
$77.8B
$6.64M 2.23%
76,990
-150
-0.2% -$13.5K
ALNY icon
19
Alnylam Pharmaceuticals
ALNY
$36.3B
$6.16M 2.07%
51,370
-435
-0.8% -$52K
IMAX icon
20
IMAX
IMAX
$2.38B
$6.05M 2.04%
150,340
+43,620
+41% +$1.69M
ABBV icon
21
AbbVie
ABBV
$458B
$5.65M 1.9%
84,093
-2,070
-2% -$135K
GLW icon
22
Corning
GLW
$126B
$5.38M 1.81%
272,620
-520
-0.2% -$11.1K
CVS icon
23
CVS Health
CVS
$137B
$5.16M 1.74%
49,225
-1,000
-2% -$102K
MDT icon
24
Medtronic
MDT
$107B
$5.02M 1.69%
67,772
– –
LLY icon
25
Eli Lilly
LLY
$1.07T
$5.02M 1.69%
60,123
-80
-0.1% -$6.1K
1
2 3 4

Similar funds

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
GHCMRT
Graham Holdings Co Master Retirement Trust Arlington, Virginia $706M AUM 7.7% 1-Year Est. Return
IFM
ION Fund Management Herzliya $707M AUM
TWM
TRB Wealth Management Houston, Texas $704M AUM
SSCM
Summit Street Capital Management New York $707M AUM 76.8% 1-Year Est. Return
NG
Northstar Group New York $707M AUM 11.67% 1-Year Est. Return
SC
Shellback Capital Boston, Massachusetts $703M AUM 53.29% 1-Year Est. Return
KM
Kora Management Brooklyn, New York $702M AUM 17.03% 1-Year Est. Return

J.P. Marvel Investment Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, J.P. Marvel Investment Advisors held 84 positions worth $297M, up 1.2% from $294M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 3.6%. J.P. Marvel Investment Advisors opened 1 new position and exited 2, leaving the 84-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 34% a quarter earlier, followed by Financials and Technology.

  • J.P. Marvel Investment Advisors's largest Q2 2015 buy was Mandiant, Inc. Common Stock: 46,020 shares worth $2.25M.
  • J.P. Marvel Investment Advisors added most to IMAX in Q2 2015, an estimated $1.69M increase.
  • J.P. Marvel Investment Advisors's biggest Q2 2015 reduction was Thermo Fisher Scientific, cutting an estimated $435K.
  • J.P. Marvel Investment Advisors fully exited AXIALL CORP COM STK (DE) in Q2 2015, selling an estimated $3.79M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 35% of its $297M portfolio in Q2 2015.
  • J.P. Marvel Investment Advisors opened 1 new position and closed 2 in Q2 2015.
  • J.P. Marvel Investment Advisors's portfolio value rose 1.2% quarter-over-quarter to $297M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q2 2015, filed 13 Aug 2015.